From: Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis
Affiliation
Type of study
Stage of disease
Nº of BRCA1/2 mutated TNBC patients
pCR
Neoadjuvant treatment
Telli 2015
PrECOG 0105 [38]
USA
Phase II Clinical Trial
I-IIIA
16
9
Cb-G-I